Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins
... Schwartz ... BACKGROUND Most patients with acute coronary syndrome (ACS) are treated with statins, which reduce atherogenic triglyceride- ... Fasting triglycerides at initial random assignment were related to risk of coronary heart disease death, nonfatal myocardial ... Myocardial Ischemia Reduction with Acute Cholesterol Lowering) trial, respectively. Analysis of dal-OUTCOMES included 15,817 ...http://liu.diva-portal.org/smash/record.jsf?pid=diva2:825326
Abstract 2216: Polyvascular Disease - A Novel Risk Factor for Worse Ischemic and Bleeding Outcomes in Acute Coronary Syndromes ...
Fondaparinux is Similar to Enoxaparin in Preventing Ischemic Events Among Patients with Acute Coronary Syndromes but Causes...
Fondaparinux is Similar to Enoxaparin in Preventing Ischemic Events Among Patients with Acute Coronary Syndromes but Causes ... coronary procedures reduce ischemic coronary events in patients with acute coronary syndromes, but increase bleeding. ... Fondaparinux is Similar to Enoxaparin in Preventing Ischemic Events Among Patients with Acute Coronary Syndromes but Causes ... Enoxaparin is a low molecular weight heparin commonly used in patients with acute coronary syndromes that reduces their risk of ...http://www.cardiologyonline.com/journal_articles/Fondaparinux.htm
Abstract 15029: Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndromes and History of Stroke or Transient...
Background: Despite current therapy, patients with acute coronary syndrome (ACS) and history of stroke or transient ischemic ... Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndromes and History of Stroke or Transient Ischemic Accident: ... Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndromes and History of Stroke or Transient Ischemic Accident: ... Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndromes and History of Stroke or Transient Ischemic Accident: ...http://circ.ahajournals.org/content/124/Suppl_21/A15029
Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome |...
Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome. ... Keywords: Acute coronary syndrome, Cardiac mortality, Hypertension, Ischemic heart disease, Optimal cardio - vascular ... Keywords: Acute coronary syndrome, Cardiac mortality, Hypertension, Ischemic heart disease, Optimal cardio - vascular ... who developed a first episode of acute coronary syndrome (ACS). Methods. The study was carried out retrospectively and included ...http://www.touchcardio.com/articles/role-optimal-medication-given-patients-hypertension-and-ischemic-heart-disease-prior-acute
The electrocardiographic differential diagnosis of ST segment depression | Emergency Medicine Journal
Acute coronary ischaemic syndromes. Acute coronary ischaemia (non-infarction). STD attributable to ischaemia is often diffuse ... Non-acute coronary ischaemic syndrome causes of ST segment depression. Intraventricular conduction disorders. Intraventricular ... STD is associated with acute coronary syndromes (ACS)-both acute ischaemia and acute infarction; this electrocardiographic ... The types of ST segment depression in the patient with acute coronary ischaemic syndrome and no evidence of infarction. (A) ...http://emj.bmj.com/content/19/2/129.full
Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive...
Power Thrombectomy in Acute Ischemic Coronary Syndromes. Topaz, On; Perin, Emerson C.; Jesse, Robert L.; Mohanty, Pramod K.; ... Intracoronary thrombi are commonly found in patients with acute coronary syndromes. A large thrombus burden or a platelet-rich ... Iron and coronary heart disease. Burt, M.J.; Halliday, J.W.; Powell, L.W. // BMJ: British Medical Journal (International ... Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive ...http://connection.ebscohost.com/c/articles/36959867/immediate-improvement-coronary-flow-reserve-after-alcohol-septal-ablation-patients-hypertrophic-obstructive-cardiomyopathy
The Evaluation of Chest Pain in the Emergency Setting - Brown Flashcards by Amanda Kroymann | Brainscape
Ischemic Heart Disease/Acute Coronary Syndrome. * thrombolytic therapy. * cardiac cath. Other cardiac or pulmonary problems ... Describe the classification of Acute Coronary Syndrome and the inital evaluation based upon 12-lead ECG findings ... Describe the classification of Acute Coronary Syndrome and the inital evaluation based upon 12-lead ECG findings ... Describe the classification of Acute Coronary Syndrome and the inital evaluation based upon 12-lead ECG findings ...https://www.brainscape.com/flashcards/the-evaluation-of-chest-pain-in-the-emerg-1957192/packs/3579975
Abstract 17948: In-vivo Visualization of Increased and Persistent Vascular Lipid Deposition by Nirs and Ivus Predicts...
Introduction: Thin-cap fibroatheromas are the pathologic cause of acute coronary syndromes and ischemic sudden death. Near ... Methods: Multi-vessel coronary angiography, IVUS and NIRS were performed 3, 6 and 9 months (m) after induction of diabetes (DM ... Five animals died of ischemic sudden death and 3 of other causes. The remaining animals were sacrificed at 9-m. ... Core 6. Catheter-Based and Surgical InterventionsSession Title: Coronary Pathobiology. Abstract 17948: In-vivo Visualization of ...http://circ.ahajournals.org/content/124/Suppl_21/A17948
Effects of fluid dynamic shear stress on platelet aggregability under pathophysiologic conditions
Increased plasma catecholamine concentrations have also been implicated in the onset of acute coronary ischemic syndromes. This ...https://scholarship.rice.edu/handle/1911/19227
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency - Full Text View -...
Acute myocardial infarction, acute coronary syndrome, transient ischemic attack, or stroke within 3 months of enrollment. ... Assessment must be performed at least 12 weeks after major cardiac surgical intervention including coronary artery bypass graft ...https://clinicaltrials.gov/ct2/show/study/NCT03037931
Statin-Induced Cholesterol Lowering and Plaque Regression After 6 Months of Magnetic Resonance Imaging-Monitored Therapy |...
Effect of atorvastatin on early recurrent ischemic events in acute coronary syndromes. JAMA. 2001; 285: 1711-1718. ... Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes. JAMA. 2003; 290: ... Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS ... explain the salutary effects of statin therapy in terms of clinical outcomes 16 weeks after an index acute coronary syndrome, ...http://circ.ahajournals.org/content/110/16/2336
Response to Letter by Xu and Liu | Stroke
Risk factors comparison in Chinese developing acute coronary syndrome, ischemic or hemorrhagic stroke: a multi-provincial ... Table 2. The Relative Risk (RR) of Ten Year Incidence Rates of Acute Ischemic Stroke and Acute Hemorrhagic Stroke in Chinese ... Trend analyses in the incidence of acute intracerebral hemorrhagic events and acute cerebral infarction events in urban area in ... Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged Chinese. Am J Cardiol. 2007; ...http://stroke.ahajournals.org/content/39/7/e104
Pharmacotherapy casebook : a patient-focused approach (Book, 2005) [WorldCat.org]
Ischemic heart disease and acute coronary syndrome / Shawn R. Hansen and Amy J. Guenette --. Ch. 12. Acute myocardial ... Drug-induced acute renal failure / Mary K. Stamatakis --. Ch. 48. Acute renal failure / Reina Bendayan and Michelle D. Furler ... Acute asthma / Tia D. Eddy, Daniel T. Kennedy and Ralph E. Small --. Ch. 25. Chronic asthma / Dennis M. Williams --. Ch. 26. ... Acute pancreatitis / Charles W. Felrow and Maria B. Yaramus --. Ch. 43. Chronic pancreatitis / Susan D. Bear and Donna S. Wall ...http://www.worldcat.org/title/pharmacotherapy-casebook-a-patient-focused-approach/oclc/57010413
Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease - Full Text View -...
Lack of known cardiovascular disease (coronary acute syndrome, stable ischemic cardiopathy, peripheric arteriopathy and ... Stable patients who coronary syndrome, cerebrovascular accident or peripheric arteriopathy event occurred at least 6 months or ...https://clinicaltrials.gov/ct2/show/NCT01449110?term=resveratrol&rank=7
Ferinject® Assessment in Patients With IRon Deficiency and Chronic Heart Failure (FAIR-HF) - Full Text View - ClinicalTrials.gov
Acute myocardial infarction or acute coronary syndrome, transient ischaemic attack or stroke within the last 3 months. ... Coronary-artery bypass graft, percutaneous intervention (e.g. cardiac, cerebrovascular, aortic; diagnostic catheters are ...https://clinicaltrials.gov/ct2/show/NCT00520780?term=iron-deficiency+anemia&rank=12
Cardiac Literature, including Myocardial Infarction, arrthymias, tachycardia, and angina sub-cluster 33
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and ... ... Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: ... ... the risk of recurrent ischemic complications in patients with non-ST-elevation acute coronary syndromes (NSTE-ACSs) remains ... molecular-weight heparin enoxaparin has been shown to decrease ischemic complications in patients with acute coronary syndromes ...http://www.biomedsearch.com/cluster/1/Cardiac-Literature-including-Myocardial-Infarction-arrthymias-tachycardia-and-angina/sub-33-p8.html
A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately...
Myocardial infarction, acute coronary syndrome, or transient ischemic attack/stroke within 6 months prior to screening ... Acute metabolic diabetic complications such as ketoacidosis or hyperosmolar coma within the past 6 months ...https://clinicaltrials.gov/ct2/show/NCT01729403?recr=Open&cond=%22Diabetes+Mellitus%2C+Type+2%22&rank=13
Inhibition of the Plasma SCUBE1, a Novel Platelet Adhesive Protein, Protects Mice Against ThrombosisSignificance |...
... within the range of elevated plasma SCUBE1 levels observed in patients experiencing acute coronary syndrome or acute ischemic ... Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic ... is significantly elevated and is a potential biomarker of platelet activation in acute coronary syndrome and acute ischemic ... Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation. 2002;105:2166-2171. ...http://atvb.ahajournals.org/content/34/7/1390
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL) - Full Text View - ClinicalTrials.gov
Acute coronary syndrome or Stroke/Transient Ischaemic Attack within the last three months ... Other contraindications to metformin (hepatic impairment, known hypersensitivity to metformin, acute illness such as ... dehydration, severe infection, shock, acute cardiac failure or suspected tissue hypoxia). *Any coexistent life threatening ...https://clinicaltrials.gov/ct2/show/NCT01483560
Yuan X[au] - PubMed - NCBI
Subclavian Steal Syndrome as a Common Denominator of Both Acute Coronary Syndrome and Ipsilateral Transient Ischemic Attack. ... Association between platelet distribution width and poor outcome of acute ischemic stroke after intravenous thrombolysis. ... Polydatin protects against acute myocardial infarction-induced cardiac damage by activation of Nrf2/HO-1 signaling. ... NLRP3 Inflammasome Formation and Activation in Nonalcoholic Steatohepatitis: Therapeutic Target for Antimetabolic Syndrome ...https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Yuan+X%5Bau%5D&dispmax=50
Clopidogrel (Professional Patient Advice) - Drugs.com
Percutaneous coronary intervention (PCI), non-acute coronary syndrome (ie, stable ischemic heart disease) (off-label use): 600 ... Percutaneous coronary intervention (PCI), non-acute coronary syndrome (ie, stable ischemic heart disease). Based on the 2011 ... Percutaneous coronary intervention (PCI) for acute coronary syndrome (eg, NSTE-ACS or STEMI) (off-label use): 600 mg (loading ... Acute coronary syndrome:. Acute ST-segment elevation myocardial infarction: To reduce the rate of myocardial infarction and ...https://www.drugs.com/ppa/clopidogrel.html
Diagnostic Dilemma | The American Journal of Medicine Blog
Double the Trouble: Acute Coronary Syndrome and Ischemic Stroke in Polycythemia Vera. August 23, 2017 Comments Off ... Double the Trouble: Acute Coronary Syndrome and Ischemic Stroke in Polycythemia Vera August 23, 2017 ... Acute Coronary Syndrome, Cardiology, diagnostic tests, stroke. Acute Coronary Syndrome, diagnostic dilemma, stroke ... American Journal of Medicine back pain Cancer cardiology Cardiomyopathy Cardiovascular Disease Clinical Research CME Coronary ...http://amjmed.org/tag/diagnostic-dilemma/
... acute coronary syndrome, stroke, or transient ischemic attack within 3 months prior to consent; bariatric surgery in the last 2 ... Pancreatitis (pancreatitis acute) was reported in one subject (empagliflozin 25 mg/linagliptin 5 mg). No subjects experienced ...http://care.diabetesjournals.org/content/38/3/394
Percutaneous Coronary Intervention for Stable Ischemic Heart Disease | SpringerLink
Coronary angiography and revascularization began in the 1960s and has evolved dramatically into a robust platform for not only ... diagnosis of coronary disease but also complex intervention. The... ... Acute myocardial infarction Percutaneous coronary intervention Acute coronary syndrome Stable ischemic heart disease Optimal ... intervention and coronary artery bypass grafting have greatly improved outcomes in the setting of acute coronary syndrome, the ...https://link.springer.com/chapter/10.1007%2F978-3-319-71635-0_18